News from Bayer
February 06, 2023
Not intended for U.S. and UK Media
Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU
January 31, 2023
Bayer to distribute pheromone-based biological crop protection solutions from M2i Group